Literature DB >> 11145271

Characterization of monoclonal antibodies generated against Norwalk virus GII capsid protein expressed in Escherichia coli.

T Yoda1, Y Terano, Y Suzuki, K Yamazaki, I Oishi, E Utagawa, A Shimada, S Matsuura, M Nakajima, T Shibata.   

Abstract

The Norwalk virus (NV) causes outbreaks of acute non-bacterial gastroenteritis in humans. The virus capsid is composed of a single 60 kDa protein. The capsid protein of NV36 (genogroup II, Mexico virus type) was expressed in an Escherichia coli system and ten monoclonal antibodies (MAbs) were generated against it. The reactivity of these MAbs was characterized using enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) analysis towards 20 overlapping fragments of the NV36 capsid protein expressed in E. coli. All of the MAbs recognized sequential (continuous) epitopes on the three antigenic regions. Six of the 10 MAbs recognized fragment 2 (equivalent residues 31-70), three MAbs recognized fragment 13 (residues 361-403) and one MAb recognized fragment 7 (residues 181-220), suggesting that the N-terminal domain (residues 1-220) may contain more antigenic epitopes than the C-terminal domain (residues 210-548). Furthermore, two MAbs (1B4 and 1F6) reacted in WB with three purified NV strains (genogroup II) derived from patients' stool samples. It was also found that genogroup I recombinant NV96-908 (genogroup I, KY89 type) could be detected as sensitively as recombinant NV36 (genogroup II) by ELISA with a set of the MAbs produced here.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11145271     DOI: 10.1111/j.1348-0421.2000.tb02582.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France.

Authors:  Béatrice Nicollier-Jamot; Valérie Pico; Pierre Pothier; Evelyne Kohli
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid.

Authors:  Tracy Dewese Parker; Noritoshi Kitamoto; Tomoyuki Tanaka; Anne M Hutson; Mary K Estes
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

5.  Single base substitutions in the capsid region of the norovirus genome during viral shedding in cases of infection in areas where norovirus infection is endemic.

Authors:  Mayumi Obara; Sumiyo Hasegawa; Masae Iwai; Eiji Horimoto; Kazuya Nakamura; Takeshi Kurata; Naohito Saito; Hiroshi Oe; Takenori Takizawa
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

6.  Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.

Authors:  Horacio Almanza; Carolina Cubillos; Iván Angulo; Francisco Mateos; José R Castón; Wim H M van der Poel; Jan Vinje; Juan Bárcena; Ignacio Mena
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

7.  Genotype 1 and genotype 2 bovine noroviruses are antigenically distinct but share a cross-reactive epitope with human noroviruses.

Authors:  S L Oliver; C A Batten; Y Deng; M Elschner; P Otto; A Charpilienne; I N Clarke; J C Bridger; P R Lambden
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP.

Authors:  Noritoshi Kitamoto; Tomoyuki Tanaka; Katsurou Natori; Naokazu Takeda; Shuji Nakata; Xi Jiang; Mary K Estes
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

9.  Precise characterization of norovirus (Norwalk-like virus)-specific monoclonal antibodies with broad reactivity.

Authors:  Tomoko Yoda; Yasuhiko Suzuki; Yoshitake Terano; Kenji Yamazaki; Naomi Sakon; Tsuyoshi Kuzuguchi; Hajime Oda; Teizo Tsukamoto
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid.

Authors:  Gabriel I Parra; Jolynn Azure; Renate Fischer; Karin Bok; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Peter Sander; Kim Y Green
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.